A "signal-on" electrochemical biosensor based on DNAzyme-driven bipedal DNA walkers and TdT-mediated cascade signal amplification strategy.


Journal

Analytica chimica acta
ISSN: 1873-4324
Titre abrégé: Anal Chim Acta
Pays: Netherlands
ID NLM: 0370534

Informations de publication

Date de publication:
01 Mar 2020
Historique:
received: 14 11 2019
revised: 30 11 2019
accepted: 03 12 2019
entrez: 29 1 2020
pubmed: 29 1 2020
medline: 13 11 2020
Statut: ppublish

Résumé

In this work, a dual amplified signal enhancement approach based on coupling deoxyribozyme (DNAzyme)-driven bipedal DNA walkers (BDW) and terminal deoxynucleotidyl transferase (TdT)-mediated DNA elongation signal amplifications has been developed for highly sensitive and label-free electrochemical detection of thrombin in human serums. In presence of thrombin, the BDW complex, which is comprised from the target thrombin and two DNAzyme-containing probes, can exhibit autonomous cleavage behavior on the surface of the substrate DNA (SD) modified electrode, and remove the cleaved DNA fragment from the electrode surface. Subsequently, the TdT can catalyze the elongation of the SD with free 3'-OH termini and formation of many G-quadruplex sequence replicates with the presence of 2'-deoxyaguanosine-5'-triphosphate (dGTP) and adenosine 5'-triphosphate (dATP) at a molar ratio of 6:4. These G-quadruplex sequences bind hemin and generate drastically amplified current response for sensitive detection of thrombin in a "signal-on" and completely label-free fashion. Under optimized conditions, the response peak current was linear with the concentration of thrombin in the range from 0.5 pM to 100000 pM with detection limit of 0.31 pM. This research provides us a sustainable idea for the hyphenated multiple amplification strategies and a stable and effective method for the detection of protein biomarkers.

Identifiants

pubmed: 31987151
pii: S0003-2670(19)31444-8
doi: 10.1016/j.aca.2019.12.008
pii:
doi:

Substances chimiques

DNA, Catalytic 0
DNA 9007-49-2
DNA Nucleotidylexotransferase EC 2.7.7.31
Thrombin EC 3.4.21.5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

40-46

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Sheng Lei (S)

College of Chemistry, Zhengzhou University, Zhengzhou, 450001, PR China.

Zi Liu (Z)

College of Chemistry, Zhengzhou University, Zhengzhou, 450001, PR China.

Lingling Xu (L)

College of Chemistry, Zhengzhou University, Zhengzhou, 450001, PR China.

Lina Zou (L)

College of Chemistry, Zhengzhou University, Zhengzhou, 450001, PR China.

Gaiping Li (G)

College of Chemistry, Zhengzhou University, Zhengzhou, 450001, PR China.

Baoxian Ye (B)

College of Chemistry, Zhengzhou University, Zhengzhou, 450001, PR China. Electronic address: yebx@zzu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH